Combined cerebrospinal fluid sCD163, MMP-9, with serum NCAM1 protein levels for predicting the prognosis of patients with tuberculous meningitis
- PMID: 40000739
- PMCID: PMC11861313
- DOI: 10.1038/s41598-025-90391-8
Combined cerebrospinal fluid sCD163, MMP-9, with serum NCAM1 protein levels for predicting the prognosis of patients with tuberculous meningitis
Abstract
Tuberculous meningitis (TBM) is the most serious type of tuberculosis infection, and there is a lack of accurate diagnostic targets for TBM. Therefore, it is of great clinical and public health significance to find a specific target for early diagnosis and prediction of the prognosis of TBM. From January 2021 to February 2024, 110 TBM patients and 122 patients with non-tumor, non-infectious headaches were admitted to Hunan Chest Hospital. To compare the two groups, cerebrospinal fluid (CSF) levels of sCD163 and MMP-9, as well as serum NCAM1 protein levels, were detected by ELISA. Multivariate logistic regression analysis or Spearman analysis was then performed to investigate the correlation between these protein levels and the MRC (Medical Research Council) stage or the short-term prognosis in TBM patients. sCD163 and MMP-9 were elevated in the CSF of TBM patients compared to controls. Oppositely, the protein levels of serum NCAM1 was decreased. The levels of CSF sCD163, MMP-9 and serum NCAM1 are associated with MRC stage and short-term prognosis of TBM patients, and the combined CSF sCD163, MMP-9 and serum NCAM1 have the best value in predicting the short-term prognosis of TBM patients.
Keywords: MMP-9; NCAM1; Prognosis; Tuberculous meningitis; sCD163.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.PLoS One. 2015 Apr 10;10(4):e0119681. doi: 10.1371/journal.pone.0119681. eCollection 2015. PLoS One. 2015. PMID: 25860354 Free PMC article.
-
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience.Mult Scler Relat Disord. 2019 Oct;35:176-181. doi: 10.1016/j.msard.2019.07.030. Epub 2019 Jul 28. Mult Scler Relat Disord. 2019. PMID: 31394405
-
Diagnostic Model for Discrimination Between Tuberculous Meningitis and Bacterial Meningitis.Front Immunol. 2021 Nov 12;12:731876. doi: 10.3389/fimmu.2021.731876. eCollection 2021. Front Immunol. 2021. PMID: 34867952 Free PMC article.
-
Detection of Delta-like 1 ligand for the diagnosis of tuberculous meningitis: An effective and rapid diagnostic method.J Int Med Res. 2014 Jun;42(3):728-36. doi: 10.1177/0300060513498669. Epub 2014 Mar 20. J Int Med Res. 2014. PMID: 24651996
-
Biomarkers of Tuberculous Meningitis and Pediatric Human Immunodeficiency Virus on the African Continent.Front Neurol. 2022 May 19;13:793080. doi: 10.3389/fneur.2022.793080. eCollection 2022. Front Neurol. 2022. PMID: 35665032 Free PMC article. Review.
References
-
- Bagcchi, S. WHO’s global tuberculosis report 2022. Lancet Microbe. 4(1), e20 (2023). - PubMed
-
- Philip, N., William, T. & John, D. V. Diagnosis of tuberculous meningitis: challenges and promises. Malays J. Pathol.37(1), 1–9 (2015). - PubMed
-
- Wilkinson, R. J. et al. Tuberculous meningitis. Nat. Rev. Neurol.13(10), 581–598 (2017). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous